European Heart Journal · 2016 · 295 citations · 26 references
MedicineCardiologyClinical CardiologyDiagnostic ImagingInterventional CardiologyCoronary AngiographyCoronary Artery DiseaseCoronary Artery ImagingOptical Coherence TomographyStent PlacementThrombosisIn-stent ThrombosisOptical Coherence Tomography AngiographyVascular Scaffolds
AIMS: Angiography has limited value for identifying the causes of stent thrombosis (ST). We studied a large cohort of patients by optical coherence tomography (OCT) to explore ST characteristics and mechanisms. METHODS AND RESULTS: A prospective multicentre registry was screened for patients with confirmed ST. Optical coherence tomography was performed after initial intervention to the culprit lesion (in 69% of cases in a deferred procedure). Stent thrombosis was classified as acute (AST), sub-acute (SAST), late (LST), and very late (VLST). Optical coherence tomography records were analysed in a central core lab. The analysis included 120 subjects aged 61.7 [51.4-70.7]; 89% male. Very late ST was the clinical presentation in 75%, LST in 6%, SAST in 15%, and AST in 4% of patients. Bare metal stents (BMS) were used in 39%, drug-eluting stents (DES) in 59% and bioresorbable vascular scaffolds in 2% of the cases. Optical coherence tomography identified an underlying morphological abnormality in 97% of cases, including struts malapposition (34%), neoatherosclerotic lesions (22%), major stent underexpansion (11%), coronary evagination (8%), isolated uncovered struts (8%), edge-related disease progression (8%), and neointimal hyperplasia (4%). Ruptured neoatherosclerotic lesions were more frequent with BMS than with DES (36 vs. 14%, P = 0.005), whereas coronary evaginations were more frequent with DES than with BMS (12 vs. 2%, P = 0.04). LST + VLST were mainly related to malapposition (31%) and neoatherosclerosis (28%), while prominent mechanisms for AST + SAST were malapposition (48%) and underexpansion (26%). CONCLUSION: In patients with confirmed ST, OCT imaging identified an underlying morphological abnormality in 97% of cases.
26
Clinical End Points in Coronary Stent Trials
Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations
2014 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2014 · 4.3K citations · Full text
Medicine, Cardiology, Surgery +14
2014 ESC/EACTS Guidelines on myocardial revascularization
Philippe Kolh, Stephan Windecker, Fernándo Alfonso et al. · European Journal of Cardio-Thoracic Surgery · 2014 · 4.2K citations · Full text
Medicine, Cardiology, Surgery +14
Predictors of Coronary Stent Thrombosis
Jochem W. van Werkum, Antonius A.C.M. Heestermans, Anoek Zomer et al. · Journal of the American College of Cardiology · 2009 · 697 citations